IperionX Limited Sponsored ADR (NASDAQ:IPX) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of IperionX Limited Sponsored ADR (NASDAQ:IPX) have been assigned a consensus rating of “Moderate Buy” from the six analysts that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation and five have issued a buy recommendation on the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $55.3333.

A number of equities research analysts recently weighed in on the stock. Roth Mkm restated a “buy” rating and set a $74.00 price objective on shares of IperionX in a research note on Tuesday, January 20th. Alliance Global Partners restated a “buy” rating on shares of IperionX in a research note on Tuesday, April 28th. Weiss Ratings restated a “sell (e+)” rating on shares of IperionX in a research note on Tuesday, April 21st. BTIG Research started coverage on shares of IperionX in a research report on Friday, March 27th. They issued a “buy” rating and a $40.00 price target on the stock. Finally, B. Riley Financial dropped their price target on shares of IperionX from $58.00 to $52.00 and set a “buy” rating on the stock in a research report on Friday, March 13th.

IperionX Stock Down 7.7%

Shares of NASDAQ IPX opened at $36.19 on Friday. IperionX has a fifty-two week low of $20.29 and a fifty-two week high of $61.45. The firm’s 50-day simple moving average is $32.90 and its 200 day simple moving average is $38.11. The company has a debt-to-equity ratio of 0.03, a quick ratio of 4.00 and a current ratio of 4.03.

IperionX (NASDAQ:IPX) last issued its quarterly earnings data on Saturday, January 31st. The company reported ($0.50) earnings per share for the quarter. On average, equities research analysts predict that IperionX will post -0.12 EPS for the current year.

Insider Activity

In other IperionX news, CEO Anastasios Arima purchased 110,000 shares of the company’s stock in a transaction on Tuesday, April 28th. The shares were purchased at an average cost of $4.49 per share, for a total transaction of $493,900.00. Following the completion of the transaction, the chief executive officer owned 12,316,782 shares in the company, valued at $55,302,351.18. The trade was a 0.90% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman Todd Hannigan purchased 260,000 shares of the company’s stock in a transaction on Wednesday, April 29th. The stock was acquired at an average price of $4.20 per share, for a total transaction of $1,092,000.00. Following the completion of the transaction, the chairman owned 26,108,334 shares of the company’s stock, valued at $109,655,002.80. This represents a 1.01% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last quarter, insiders acquired 590,000 shares of company stock worth $2,571,500.

Institutional Investors Weigh In On IperionX

Hedge funds and other institutional investors have recently bought and sold shares of the business. Jones Financial Companies Lllp bought a new stake in IperionX in the third quarter worth about $36,000. JPMorgan Chase & Co. bought a new stake in IperionX in the second quarter worth about $66,000. State of Tennessee Department of Treasury bought a new stake in IperionX in the fourth quarter worth about $119,000. DV Equities LLC acquired a new stake in IperionX during the 4th quarter worth about $178,000. Finally, Vanguard Personalized Indexing Management LLC acquired a new stake in IperionX during the 3rd quarter worth about $297,000. 2.76% of the stock is currently owned by institutional investors.

IperionX Company Profile

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.